OpenAI and US FDA hold talks about using AI in drug evaluation: Report

OpenAI and the U.S. Food and Drug Administration have been meeting to discuss the health regulator's use of AI, technology news platform Wired reported on Wednesday, citing sources with knowledge of the meetings.

Sources close to the project say a small team from OpenAI has met with the FDA and two associates of Elon Musk's so-called Department of Government Efficiency multiple times in recent weeks, according to the report.